<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A ligand for the flt3 tyrosine kinase receptor (flt3R) has recently been cloned </plain></SENT>
<SENT sid="1" pm="."><plain>Forty-three cases of childhood <z:hpo ids='HP_0004808'>acute myeloid leukemia</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>) and 27 cases of childhood <z:hpo ids='HP_0011009'>acute</z:hpo> lymphocytic <z:hpo ids='HP_0001909'>leukemia</z:hpo> (ALL) were examined by flow cytometric analysis for cell-surface flt3R and proliferative response in vitro to flt3 ligand (flt3L) </plain></SENT>
<SENT sid="2" pm="."><plain>Flt3R was commonly expressed on the cell surface of leukemic cells from <z:hpo ids='HP_0000001'>all</z:hpo> <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> subclasses and <z:e sem="disease" ids="C0023435" disease_type="Neoplastic Process" abbrv="">B-ALL</z:e>, but we did not detect cell-surface flt3R on <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">T-ALL</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>Flt3L alone induced the proliferation of the monocytic <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>-M5 cells and some erythroleukemic <z:e sem="disease" ids="C0023440" disease_type="Neoplastic Process" abbrv="">AML-M6</z:e> cells </plain></SENT>
<SENT sid="4" pm="."><plain>Some isolated instances of weak proliferative responses were also noted in other <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> subclasses </plain></SENT>
<SENT sid="5" pm="."><plain>Interleukin-4 (IL-4) alone inhibited the proliferation of a group of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>-M5 cells and, when combined with flt3L, suppressed the proliferative effect of flt3L </plain></SENT>
<SENT sid="6" pm="."><plain>In general, <z:e sem="disease" ids="C0023435" disease_type="Neoplastic Process" abbrv="">B-ALL</z:e> and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">T-ALL</z:e> cells failed to respond to flt3L alone or in the presence of combinations of IL-2, IL-3, or IL-7 </plain></SENT>
</text></document>